10.4827
0.2227 (2.17%)
0.2227 (2.17%)
Upgrade to Real-Time
Regular Market
Low
3.59
High
80.67
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Brooklyn ImmunoTherapeutics Inc | BTX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.2227 | 2.17% | 10.4827 | 13:42:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.27 | 10.03 | 10.86 | 10.26 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,360 | 649,973 | $ 10.47 | $ 6,806,168 | - | 3.59 - 80.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:42:42 | 100 | $ 10.4827 | USD |
Period:
Draw Mode:
Brooklyn ImmunoTherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 542.27M | 51.73M | 35.91M | $ - | $ - | -0.64 | -16.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 3.07M | 15.10% |
Brooklyn ImmunoTherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.86 | 12.81 | 9.36 | 11.67 | 2,153,891 | 0.6227 | 6.32% |
| 1 Month | 20.00 | 23.34 | 9.36 | 15.25 | 2,599,273 | -9.52 | -47.59% |
| 3 Months | 71.00 | 80.67 | 9.36 | 25.95 | 5,347,186 | -60.52 | -85.24% |
| 6 Months | 4.90 | 80.67 | 3.59 | 28.85 | 7,305,829 | 5.58 | 113.93% |
| 1 Year | 4.90 | 80.67 | 3.59 | 28.85 | 7,305,829 | 5.58 | 113.93% |
| 3 Years | 2.52 | 80.67 | 0.66 | 22.97 | 2,265,112 | 7.96 | 315.98% |
| 5 Years | 3.02 | 80.67 | 0.66 | 19.09 | 1,143,095 | 7.46 | 247.11% |
Brooklyn ImmunoTherapeut... Description
| Brooklyn ImmunoTherapeutics Inc is a clinical stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. |
